COG6 (Conserved Oligomeric Golgi Complex 6) is a critical subunit of the COG complex, an essential hetero-octameric assembly governing Golgi apparatus function. The COG complex coordinates vesicular trafficking and maintains Golgi stack integrity, with COG6 specifically contributing to lobe B structure and function.
| Symbol | COG6 |
|---|---|
| Full Name | Conserved Oligomeric Golgi Complex 6 |
| Chromosomal Location | Chr13q14.11 |
| NCBI Gene ID | 120893 |
| UniProt ID | Q9Y5J4 |
| Associated Diseases | CDG IIl, Saul-Wilson syndrome |
COG6 (approximately 657 amino acids) forms the structural core of lobe B in the COG complex. It directly interacts with COG5, COG7, and COG8, and bridges to lobe A through associations with COG3. The protein contains multiple coiled-coil domains that mediate protein-protein interactions essential for complex assembly [1][2]. [1]
The COG complex functions as a multisubunit tethering complex (MTC), coordinating the final stages of vesicle docking before SNARE-mediated membrane fusion. COG6 specifically participates in: [2]
The COG complex regulates bidirectional trafficking between Golgi compartments and between the Golgi and endoplasmic reticulum. This trafficking is essential for:
Proper protein glycosylation requires sequential enzyme activities distributed across Golgi cisternae. COG6 maintains the subcompartmental organization necessary for ordered glycan processing [5].
Golgi fragmentation in AD neurons correlates with cognitive decline. COG6 dysfunction may contribute to altered amyloid precursor protein (APP) processing and impaired trafficking of presenilin (γ-secretase) [6][7].
The COG complex supports lysosomal trafficking pathways critical for clearing alpha-synuclein. COG6 deficiency impairs autophagosome-lysosome fusion, potentially accelerating protein aggregate accumulation [8].
COG6 mutations have been implicated in hereditary spastic paraplegia (HSP), characterized by axonal degeneration of corticospinal tract neurons [9].
COG6 mutations cause CDG IIl (OMIM #614576), presenting with severe neurological impairment, including developmental delay, microcephaly, and seizures. The phenotype reflects the critical importance of COG-mediated trafficking for neuronal development and function [10][11].
Specific COG6 variants cause Saul-Wilson syndrome, a skeletal dysplasia with additional neurological manifestations [12].
COG6 interacts with:
Understanding COG6 function informs therapeutic development for neurodegenerative diseases:
Ferreira et al. Saul-Wilson (2018). 2018. ↩︎
Sutton et al. Therapeutic Golgi (2023). 2023. ↩︎